Cellectis SA (CLLS)
2.54
-0.02
(-0.78%)
USD |
NASDAQ |
May 01, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
Cellectis 1 Year Total Returns (Daily): 36.17% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 30, 2024 | 36.17% |
| April 29, 2024 | 36.17% |
| April 26, 2024 | 31.18% |
| April 25, 2024 | 28.35% |
| April 24, 2024 | 29.53% |
| April 23, 2024 | 37.88% |
| April 22, 2024 | 38.95% |
| April 19, 2024 | 25.62% |
| April 18, 2024 | 22.89% |
| April 17, 2024 | 20.59% |
| April 16, 2024 | 22.06% |
| April 15, 2024 | 27.94% |
| April 12, 2024 | 31.22% |
| April 11, 2024 | 41.41% |
| April 10, 2024 | 42.35% |
| April 09, 2024 | 39.59% |
| April 08, 2024 | 36.55% |
| April 05, 2024 | 35.35% |
| April 04, 2024 | 39.59% |
| April 03, 2024 | 38.81% |
| April 02, 2024 | 37.31% |
| April 01, 2024 | 31.61% |
| March 28, 2024 | 30.22% |
| March 27, 2024 | 34.17% |
| March 26, 2024 | 25.98% |
| Date | Value |
|---|---|
| March 25, 2024 | 26.47% |
| March 22, 2024 | 27.55% |
| March 21, 2024 | 26.50% |
| March 20, 2024 | 29.29% |
| March 19, 2024 | 28.19% |
| March 18, 2024 | 32.45% |
| March 15, 2024 | 38.80% |
| March 14, 2024 | 27.78% |
| March 13, 2024 | 30.61% |
| March 12, 2024 | 31.66% |
| March 11, 2024 | 22.11% |
| March 08, 2024 | 19.91% |
| March 07, 2024 | 16.20% |
| March 06, 2024 | 16.67% |
| March 05, 2024 | 16.43% |
| March 04, 2024 | 22.07% |
| March 01, 2024 | 20.45% |
| February 29, 2024 | 16.74% |
| February 28, 2024 | 15.38% |
| February 27, 2024 | 24.77% |
| February 26, 2024 | 21.16% |
| February 23, 2024 | 24.67% |
| February 22, 2024 | 28.48% |
| February 21, 2024 | 24.35% |
| February 20, 2024 | 21.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.75%
Minimum
Jun 14 2022
172.9%
Maximum
Mar 22 2021
-21.80%
Average
-36.33%
Median
1 Year Total Returns (Daily) Benchmarks
| DBV Technologies SA | -55.60% |
| Genfit SA | -12.50% |
| Biophytis SA | -94.09% |
| Edap TMS SA | -34.60% |
| Biodexa Pharmaceuticals Plc | -91.88% |